Literature DB >> 14557880

Interleukin-3-producing CD4+ T-cells support eosinophil survival in a patient with transient hypereosinophilia.

Shin-ichi Toyabe1, Waka Harada, Makoto Uchiyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14557880     DOI： 10.1007/s00431-003-1325-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  6 in total

Review 1.  Clonal eosinophilic disorders and the hypereosinophilic syndrome.

Authors:  F Brito-Babapulle
Journal:  Blood Rev       Date:  1997-09       Impact factor: 8.250

2.  Spontaneous remission of a massive CNS inflammation with eosinophilic infiltrate.

Authors:  Yoshiko Tamaru; Mayumi Nakashita; Hidefumi Ito; Ryosuke Okumura; Sadayuki Matsumoto; Terukuni Imai
Journal:  Intern Med       Date:  2003-05       Impact factor: 1.271

3.  Inverse PCR amplification of rare T cell receptor delta messages from mucosal biopsy specimens.

Authors:  Y Chowers; W Holtmeier; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Immunol Methods       Date:  1995-02-27       Impact factor: 2.303

Review 4.  NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

Authors:  A S Fauci; J B Harley; W C Roberts; V J Ferrans; H R Gralnick; B H Bjornson
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

5.  Interleukin-5 mRNA levels in blood and bone marrow mononuclear cells from patients with the idiopathic hypereosinophilic syndrome.

Authors:  T Satoh; L Sun; M S Li; C J Spry
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

6.  Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.

Authors:  H Schrezenmeier; S D Thomé; F Tewald; B Fleischer; A Raghavachar
Journal:  Exp Hematol       Date:  1993-02       Impact factor: 3.084
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.